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See related review article by Jacob et al., http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1485-0
We read with interest the article by Jacob and colleagues
[1] on the regulation of microcirculatory blood flow. In our
opinion, the authors missed an important parameter, i.e.,
blood components and, particularly, red blood cells (RBC).
This is regrettable since blood composition is the main par-
ameter that we can influence by our therapies (fluid resus-
citation, blood or albumin transfusion) in shocked patients.
RBC may use different contradictory pathways to
modulate microvascular flow by modifying nitric oxide
(NO) bioavailability, which is responsible for precapillary
dilatation and capillary perfusion.
On the one hand, erythrocytes may reduce NO
bioavailability through hemoglobin NO scavenging; on
the other hand, enhancing hematocrit may increase
viscosity and wall shear stress (WSS), a crucial agonist
enabling endothelium NO release.
Thus, in hypoxic conditions, RBC may sense tissue oxygen
tension and release vasodilatory agents such as NO or ATP.
In moderate hemodilution, blood viscosity is reduced,
cardiac output increases, wall shear rate (WSR; blood
velocity) increases and WSS is unchanged (WSS =WSR×
viscosity). NO bioavailability increases because of reduced
NO scavenging by erythrocytes, leading to systemic
vasoplegia. In extreme hemodilution [2] (hematocrit at
11%), viscosity, WSR, and WSS drop. Functional capillary
density (FCD), which reflects microcirculatory flow, de-
creases. In this model, enhancing blood viscosity with high
viscosity-plasma expander increased FCD. In the same way,
in a murine model of hemorrhagic shock, transfusion of
fresh RBC without oxygen-carrying capacity restored blood
viscosity, and enhanced FCD, microvascular flow, and sys-
temic hemodynamics. Recently, Tanaka and colleagues [3]
observed that RBC transfusion improved sublingual FCD in
humans in hemorrhagic shock with active blood loss.
We have known since 1999 from the results of a trial
using modified human hemoglobin in traumatic
hemorrhagic shock [4] that modifying blood properties
could be harmful. Patients in this study had a better blood
systolic pressure than control patients, but more of them
died. Free hemoglobin scavenges NO, enhancing precapil-
lary vasoconstriction and impairing capillary perfusion.
We do not share the authors’ opinion that it is “better to
choose hemorrhagic rather than septic shock for yourself”.
Guidelines for traumatic hemorrhagic shock management
[5] do not consider RBC transfusion for their microcircula-
tory properties and viscosity improvement, but only for
their oxygen-delivering capacity, which is altered for many
hours after transfusion, when blood is stored. Recommend-
ing a low hemoglobin trigger delays RBC transfusion when
microcirculation flow is already impaired.
Authors’ response
Matthias Jacob, Daniel Chappell and Bernhard F. Becker
Nicolas Morel and Marie Moisan have drawn attention
to the special but confounding role played by RBC in
modulating regional microcirculatory flow distribution.
As they correctly point out, contributory effects include
changes in blood viscosity and scavenging or provision
of vasoactive metabolites. Such influences must be ex-
pected, especially in conjunction with transfusions of
RBC in situations of treatment or prevention of shock
[6]. Although the effect of blood transfusion on blood
viscosity and flow resistance has fascinated physiologists
and experimental clinicians for over 100 years, the
action of RBC on blood flow distribution has not been
resolved satisfactorily. This is, in part, due to the fact
that microvascular flow resistance arises mainly from
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the leukocyte component of whole blood, and not from
RBC-mediated changes in viscosity [7]. With respect to
scavenging of endothelium-derived vasodilatory NO by
the hemoglobin of RBC, such an effect may be coun-
tered by the recently described presence of an active
type-3 NO synthase in RBC [8]. In addition, supplying
oxygen to the tissue provokes the production of
vasoconstrictors in vivo. This realization has disproved
other hypotheses proposing oxygen-dependent destruc-
tion or removal of vasodilators by RBC [9].
These few examples of the problems still associated
with understanding the mechanisms by which RBC may
influence regional flow distribution illustrate the contin-
ued necessity of conducting well-planned clinical studies
for the improvement of patient outcome in situations of
shock. Although at first sight the approach to manage-
ment of traumatic hemorrhagic shock seems more clear
than that of septic states, Morel and Moisan have
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